ReviewCancer chemotherapy and pharmacology2026

ALK rearrangements and resistance mutations in non-small cell lung cancer: molecular mechanisms and therapeutic implications.

Palani Bharath et al.PubMed ↗Publisher ↗

No numbers read from the abstract.